by Admin | Apr 28, 2021 | News & Opinions
MIAMI, April 27, 2021 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for chronic, aging-related and life-threatening conditions,...
by Admin | Apr 27, 2021 | News & Opinions
ALACHUA, Fla. (PRWEB)April 21, 2021 – Cardiovascular disease kills more than 650,000 Americans annually.(1) Those who survive myocardial infarction remain at risk of death because the human heart has a very limited ability to repair itself. No one has yet found...
by Admin | Apr 23, 2021 | News & Opinions
By: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research Link to article The U.S. Food and Drug Administration plays a vital role in facilitating the development and availability of innovative medical products. Products such as...
by Admin | Apr 20, 2021 | News & Opinions
Durham, NC – A phase 2 clinical trial whose results were released today in STEM CELLS Translational Medicine might point to a way to overcome bronchopulmonary dysplasia (BPD), a major cause of death in preterm infants. The study, conducted by researchers at...
by Admin | Apr 19, 2021 | News & Opinions
Durham, NC – A study released today in STEM CELLS Translational Medicine suggests a new way to correct facial atrophy of localized scleroderma (LoS) in patients. It shows how applying grafts made up of the patient’s own fat enhanced with adipose‐derived stem cells...
by Admin | Apr 13, 2021 | News & Opinions
Wellington, FL — On June 14-18, 2021, the Regenerative Medicine Foundation (RMF) and Wake Forest Institute for Regenerative Medicine (WFIRM) will broadcast the combined event showcasing global experts, luminaries and visionaries from government, science, medicine,...
